Sanja Kogelnik's Discussions (40)

Search Discussions

View

Discussions Replied To (26) Replies Latest Activity

" Unfortunately, mutation out of frame leads to DMD :( "

Sanja Kogelnik replied Jul 16, 2017 to Duplication of Exon 53 to 57 out of frame

 1 Jul 16, 2017
Reply by Sanja Kogelnik

"Dear Galia, thank you very much for sharing this news with us. You give me new stren…"

Sanja Kogelnik replied Feb 20, 2017 to Tamoxifen

 47 Jan 21
Reply by Sandro

"Hi Sai, Unfortunately, in your case, exon skipping is not an option.  But Ezutromid…"

Sanja Kogelnik replied Feb 13, 2017 to Exon 44 Deletion

 23 Feb 13, 2017
Reply by Sai Chand. Gurujala

"This is encouraging news. So this is yet another option for the treatment of DMD. No…"

Sanja Kogelnik replied Feb 12, 2017 to Tamoxifen

 47 Jan 21
Reply by Sandro

"Dear Galia, thanks for sharing this great news ;)"

Sanja Kogelnik replied Feb 10, 2017 to Tamoxifen

 47 Jan 21
Reply by Sandro

"Hi Sai, As far as I know, the vitamin is not mutation specific... so  yes, you can…"

Sanja Kogelnik replied Feb 10, 2017 to Nicotinamide riboside

 18 Feb 10, 2017
Reply by Sanja Kogelnik

"Hey Goran, his email address is : johan.auwerx@epfl.ch I think he Will advice you t…"

Sanja Kogelnik replied Feb 6, 2017 to Nicotinamide riboside

 18 Feb 10, 2017
Reply by Sanja Kogelnik

"Really? I am very happy to hear that, then it means that this is working. I'll link…"

Sanja Kogelnik replied Feb 1, 2017 to Nicotinamide riboside

 18 Feb 10, 2017
Reply by Sanja Kogelnik

"For now I will give as much as dr. Auwerx recommended. This brand is good, but conta…"

Sanja Kogelnik replied Feb 1, 2017 to Nicotinamide riboside

 18 Feb 10, 2017
Reply by Sanja Kogelnik

"I hawe wtitten with him too. He suggest 250 mg daily ( my son is 2y and have 12 kg).…"

Sanja Kogelnik replied Feb 1, 2017 to Nicotinamide riboside

 18 Feb 10, 2017
Reply by Sanja Kogelnik

RSS

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2018   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service